Merck & Co./MRK

$127.12

0.96%
-
1D1W1MYTD1YMAX

About Merck & Co.

Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. It sells these human health pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, and health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. The Company’s lead candidate, MK-6070, is a T-cell engager targeting delta-like ligand 3 (DLL3), an inhibitory canonical Notch ligand.

Ticker

MRK

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Robert Davis

Employees

72,000

Headquarters

Rahway, United States

Merck & Co. Metrics

BasicAdvanced
$319B
Market cap
141.34
P/E ratio
$0.89
EPS
0.40
Beta
$3.00
Dividend rate
2.44%
Dividend yield
$319B
0.40444
$133.10
$99.14
8.3M
$3.00
1.253
0.993
77.153
84.776
331.66%
6.55%
2.17%
5.29%
2.81%
141.344
5.201
7.912
198.238
91.298
2.85%
2.38%
2.44%
6.11%
-82.59%
13.13%
-56.81%
6.08%

What the Analysts think about Merck & Co.

Analyst Ratings

Majority rating from 28 analysts.
Buy

Price Targets

Average projection from 25 analysts.
11.85% upside
High $155.00
Low $118.00
$127.12
Current price
$142.18
Average price target

Merck & Co. Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
30.18% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$16B
7.83%
Net income
$4.8B
-488.42%
Profit margin
30.18%
-460.14%

Merck & Co. Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 10.4%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$2.06
$2.13
$0.03
$2.07
-
Expected
-$2.18
$1.95
-$0.11
$1.88
$2.14
Surprise
-5.39%
9.17%
-127.48%
10.4%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Merck & Co. stock?

Merck & Co. (MRK) has a market cap of $319B as of May 30, 2024.

What is the P/E ratio for Merck & Co. stock?

The price to earnings (P/E) ratio for Merck & Co. (MRK) stock is 141.34 as of May 30, 2024.

Does Merck & Co. stock pay dividends?

Yes, the Merck & Co. (MRK) stock pays dividends to shareholders. As of May 30, 2024, the dividend rate is $3 and the yield is 2.44%. Merck & Co. has a payout ratio of 331.66% on a trailing twelve-month basis.

When is the next Merck & Co. dividend payment date?

The next Merck & Co. (MRK) dividend payment is scheduled for July 08, 2024.

What is the beta indicator for Merck & Co.?

Merck & Co. (MRK) has a beta rating of 0.4. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Merck & Co. stock price target?

The target price for Merck & Co. (MRK) stock is $142.18, which is 11.85% above the current price of $127.12. This is an average based on projections from 25 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Merck & Co. stock

Buy or sell Merck & Co. stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing